TTR and neoplasm: Changes in expression levels of factors known to modulate tumor growth through immune recruitment (ie, CCL7, CCL8, ICAM) by resistance to death (ieTrxR, Trx, HIF‐1), and metastasis (ie, MMPs, ADAMs, ILs, Cts) may drive the inhibition observed.